Amaryllis Study

Study Sponsor: Pfizer

Phase: Phase II, Safety and Efficacy

Clinical Sites in NC: Wake Forest


amaryllisThe purpose of the study is to find out if the investigational drug PF-02545920 is safe and if it will have beneficial effects in participants with Huntington’s disease. The study will measure the safety and effects of a new drug on movements, mental abilities and behavior in people with Huntington’s disease.